Yahoo Web Search

Search results

  1. Blanche & Irwin Lerner. Irwin Lerner (BS'51, MBA'58), the former chair, president, and CEO of Hoffmann-La Roche, is a highly regarded industry pioneer. He led industry reforms that streamlined Federal Drug Administration (FDA) drug approvals; oversaw passage of the Prescription Drug User Fee legislation, which expedited the approval process by ...

  2. Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues. Just as the state of New Jersey is recognized as the nation’s principal pharmaceutical hub, Rutgers Business School (RBS) has evolved as an academic leader in pharmaceutical management training and research.

    • Blanche Lerner1
    • Blanche Lerner2
    • Blanche Lerner3
    • Blanche Lerner4
    • Blanche Lerner5
  3. discussion and debate at the 2018 Lerner Center Annual Healthcare Symposium hosted by Rutgers University. At the symposium, members representing every facet of the healthcare system assembled to discuss biopharmaceutical innovation challenges through conversations led by key industry executives.

  4. Lerner Center for the Study of Pharmaceutical Management Issues, Newark. 56 likes. Blanche and Irwin Lerner Center for the Study of Pharmaceutical...

  5. The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues 1 Washington Park, #1125B, Newark, NJ 07102. 1. Director’s Message. It gives me great pleasure to present to you the seventh issue of the Lerner Center’s Newlett er.

  6. A giant of the biopharmaceutical industry, Irwin M. Lerner, Rutgers MBA, former chairman and chief executive of Roche, is the man behind the Blanche and Irwin Lerner Center for the study of ...

    • 3 min
    • 1088
    • Rutgers Business School - Newark & New Brunswick
  7. The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues 1 Washington Park, #1125B Newark, NJ 07102 2 “the enemy is not medical costs or reimbursement, but rather the chronic conditions.” Annual Healthcare Symposium Unleashing the Promise of Biotechnology: Advancing